Facebook Linkedin Twitter
Inside Precision Medicine Merck’s First-in-Class Drug for Pulmonary Arterial Hypertension Approved by the FDA

Merck & Co

Close-up of Internal organs dummy on white background. Human anatomy model. Heart Anatomy Internal.
News & Features

Merck’s First-in-Class Drug for Pulmonary Arterial Hypertension Approved by the FDA

Chris Anderson -
0
Blended Face of Men and Woman
News & Features

Breaking Down Sex and Gender Barriers in Search of Precision Medicine

Helen Albert -
0
Scientist pipetting sample into a vial for DNA testing
News & Features

Merck and Owkin Partner on AI-Powered Precision Cancer Tests

Malorye Branca -
0
PD-1 Antibody Targeting Immune Checkpoint Inhibitor
News & Features

Merck Bets Big on ADCs with $4B+ Daiichi Sankyo Deal

Malorye Branca -
0
Ubiquitin activating enzyme protein E1
News & Features

Proxygen Nets Deal Worth Up to $2.55B with Merck around Glue Degraders

Malorye Branca -
0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

Pfizer Acquires ADC Developer Seagen in $43B Deal

Malorye Branca -
0
Ubiquitin activating enzyme protein E1
News & Features

Protein Enhancement Therapeutics Company Entact Bio Raises $81M in Series A Round

Chris Anderson -
0
doctor hold coronavirus vaccine in hospital laboratory
Molecular Dx

Orna Scores Merck Collaboration and $221M Series B

Malorye Branca -
0
PerkinElmer lab
Coronavirus

Merck Will Apply for EUA of COVID-19 Antiviral in Wake of Promising Phase III Data

Alex Philippidis -
0
The Lab
Coronavirus

Merck Discontinues Development of 2 COVID-19 Vaccines

Alex Philippidis -
0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine